• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Neutrophil Counts Linked to Cognitive Performance in Depressive Disorders

by
November 16, 2026
in Health
Reading Time: 6 mins read
0
Neutrophil Counts Linked to Cognitive Performance in Depressive Disorders

Neutrophil Counts Linked to Cognitive Performance in Depressive Disorders

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Routine hematological and metabolic markers, particularly neutrophil counts, may provide insights into cognitive performance among patients with depressive disorders, according to an exploratory cross-sectional study. Researchers at Xiamen Xianyue Hospital evaluated 160 outpatients to determine if common clinical indicators—including white blood cell counts, neutrophil levels, and metabolic measures like total cholesterol—correlate with cognitive function. The study, which included participants between the ages of 13 and 75, aimed to bridge the gap in understanding how systemic immune and metabolic states might mirror cognitive vulnerability in psychiatric populations. By analyzing data from standardized cognitive screenings alongside routine fasting blood chemistry, the team identified statistical associations that warrant further investigation as potential tools for cognitive risk stratification in real-world clinical settings.

In the primary analytic sample of 160 patients, statistical models revealed an inverse relationship between neutrophil counts and raw scores on cognitive assessments, such as the Chinese Mini-Mental Status (CMMS) or the Montreal Cognitive Assessment (MoCA). This association remained significant even after controlling for demographic variables, illness duration, and symptom severity as measured by the Zung Self-Rating Depression Scale (SDS). The study suggests that while these peripheral markers are not direct measures of neuroinflammation, they may capture broader systemic physiological states that influence brain health. The researchers reported that their adjusted model, which included age, sex, BMI, illness duration, and educational attainment, explained 34.1% of the observed variance in cognitive performance, highlighting the complexity of these interactions.

Beyond immune markers, total cholesterol levels were found to have a nominal inverse correlation with cognitive performance in the full study group. However, the authors emphasized that this specific finding did not reach statistical significance after correcting for multiple comparisons, categorizing it as exploratory. While metabolic dysregulation has long been proposed as a factor in the pathophysiology of depression-related cognitive impairment—potentially affecting neuronal membrane integrity or blood-brain barrier permeability—the current data do not confirm a direct causal link. The study maintains that these results reflect systemic markers rather than specific mechanistic pathways, and the nominal associations observed in the overall cohort necessitate further validation in larger, longitudinal studies.

To investigate developmental differences, the research team conducted exploratory subgroup analyses, categorizing participants into adolescents under 18 years of age and adults aged 18 and older. These analyses suggested that the inverse association between neutrophil counts and cognitive scores might be more pronounced in the adult subgroup. Despite these descriptive patterns, formal interaction tests between age groups and biomarkers failed to yield statistically significant results. The researchers concluded that these subgroup findings should be interpreted with caution, as they remain hypothesis-generating rather than confirmatory evidence of age-specific effects, particularly given the relatively small sample size of the adolescent group and the overall study design.

The study utilized a cross-sectional design, which inherently limits the ability to draw causal inferences regarding the relationships between hematological indicators and cognitive function. The researchers noted that reverse causality remains a significant consideration; for instance, cognitive difficulties could theoretically influence dietary habits, physical activity, or treatment adherence, which in turn could impact metabolic markers. Furthermore, the study relied on clinical screening instruments, the CMMS and MoCA, which differ in sensitivity and content. While educational attainment was included in the multivariable models to address potential bias, the use of raw scores from two different instruments remains a limitation that may introduce measurement heterogeneity.

Additional covariates, such as the use of specific antidepressant medications, smoking, sleep quality, and socioeconomic status, were not comprehensively captured in the final dataset. The study also lacked specific measures of systemic inflammation, such as cytokine levels or neuroimaging indices, which would be necessary to delineate the precise biological mechanisms connecting peripheral immune markers to cognitive outcomes. The authors acknowledged that while the integration of these routinely available tests into clinical practice could potentially help identify patients requiring closer cognitive monitoring, such a move remains premature without external validation and a more granular understanding of the underlying pathways.

Looking toward future research, the team advocates for longitudinal studies designed to track changes over time, incorporating more specific inflammatory markers and standardized, domain-specific cognitive assessments. By employing larger and more diverse cohorts, future investigations may be better equipped to test age-specific interactions and determine whether the observed correlations are stable across different stages of development and aging. The researchers also suggest that animal models, particularly those exploring the gut-brain axis, could help clarify the potential biological connections between immune-metabolic dysregulation and cognitive function. Such efforts would be essential for moving from exploratory clinical observations to evidence-based risk assessment protocols.

Ultimately, the study highlights the potential utility of accessible clinical indicators in understanding the multifaceted nature of cognitive impairment in depressive disorders. While the associations between neutrophil counts, total cholesterol, and cognitive performance provide a pragmatic starting point, the researchers consistently emphasize the exploratory nature of their conclusions. The findings do not establish a unified immune-metabolic mechanism nor do they support the use of these markers as standalone clinical tools at this stage. Instead, the study provides a foundation for future inquiry into how routine laboratory data might one day contribute to a more personalized approach to monitoring and treating cognitive health in patients with mood disorders.

To establish a well-characterized outpatient cohort, participants were consecutively recruited from mood disorder clinics and underwent rigorous clinical evaluation. Diagnosis was confirmed by board-certified psychiatrists using the Structured Clinical Interview for DSM-5 to verify major depressive disorder or related conditions like persistent depressive disorder. To prevent confounding factors from skewing hematological and metabolic indicators, the investigators enforced stringent exclusion criteria. Patients were excluded if they experienced acute infections or inflammatory conditions within the preceding two weeks, had autoimmune illnesses such as rheumatoid arthritis, or managed severe metabolic disturbances including uncontrolled diabetes. Individuals with a history of substance use disorders in the past six months, pregnancy, lactation, or cognitive impairment stemming from traumatic brain injury or dementia were likewise omitted. In addition, candidates who received immunosuppressive or anti-inflammatory therapies during the month prior to enrollment were excluded, ensuring that measured biological markers reflected baseline physiology rather than recent pharmacological suppression.

Fasting blood collection followed a standardized protocol designed to limit circadian variability across the study sample. Venous blood draws of ten milliliters were gathered strictly between 8:00 AM and 10:00 AM. Hematological profiling was conducted using an automated Sysmex XN-1000 analyzer to quantify white blood cell counts alongside specific leukocyte subtypes, including neutrophils, lymphocytes, monocytes, and eosinophils. Metabolic parameters were assayed on an automated Beckman Coulter AU5800 platform, evaluating total cholesterol, triglycerides, alanine aminotransferase, and aspartate aminotransferase under standard clinical laboratory quality controls. While neutrophil counts and total cholesterol demonstrated notable bivariate associations with cognitive performance, other evaluated indicators revealed no meaningful relationships. Specifically, circulating levels of triglycerides, alanine aminotransferase, and aspartate aminotransferase did not show statistically significant associations with cognitive scores, and exploratory statistical modeling found no evidence of a quadratic or nonlinear relationship between total cholesterol and cognition.

Clinical assessments also highlighted direct links between affective symptom severity and peripheral immune activity. Depressive symptoms evaluated with the Zung Self-Rating Depression Scale averaged 62.31, while anxiety symptoms measured by the Zung Self-Rating Anxiety Scale averaged 58.24, placing the overall cohort within moderate-to-severe symptom ranges above the standard clinical cutoff of 50. Correlation analyses indicated that greater depressive symptom severity correlated positively with both neutrophil counts and monocyte counts. Concurrently, heightened anxiety severity showed a statistically significant positive correlation with total white blood cell counts. These patterns support observations that affective illness severity corresponds to broader systemic immune activation, although the researchers cautioned that circulating cell counts represent nonspecific biological responses that can fluctuate with acute stress, sleep disruption, and unmeasured clinical variations.

In the multivariable linear regression model predicting cognitive performance, individual predictors provided nuanced insights into cognitive vulnerability. Beyond neutrophil count and total cholesterol, poorer cognitive scores were significantly associated with older age, longer illness duration, and higher depression severity scores on the depression scale. Conversely, greater educational attainment was positively associated with cognitive performance. All variance inflation factors remained comfortably below 5, confirming that multicollinearity did not distort the estimated regression coefficients. When examining specific testing instruments, older patients with lower educational backgrounds completed the Chinese Mini-Mental Status examination, which uses education-stratified diagnostic thresholds, while younger or more educated individuals were evaluated with the Montreal Cognitive Assessment. Across the entire cohort of 160 patients, the mean cognitive score was 25.77 on the native 30-point metric, reflecting mild screening-level reductions across diverse clinical presentations.

Demographic and physiological comparisons between age cohorts further clarified developmental baseline characteristics. Adult participants demonstrated significantly higher body mass index, illness duration, neutrophil counts, monocyte counts, total cholesterol, and triglyceride concentrations than adolescent participants, despite showing equivalent sex distribution, depressive severity, anxiety levels, and overall cognitive screening scores. In exploratory sensitivity testing dividing the cohort into adolescents, adults aged 18 to 60, and older adults over 60, the small size of the older adult subset underscored the statistical power constraints of age-stratified analyses. To resolve these uncertainties, the authors emphasized the necessity of prospective studies evaluating mechanistic immune markers such as C-reactive protein, interleukin-6, and tumor necrosis factor-alpha, alongside comprehensive metabolic panels measuring fasting glucose, insulin resistance, and glycated hemoglobin. Such targeted laboratory evaluations, combined with formal clinical trials targeting lifestyle modifications or metabolic risk factors, could ultimately clarify whether peripheral immune-metabolic changes actively influence cognitive outcomes across the human lifespan.

Subject of Research: Clinical psychiatry and immunology regarding cognitive function in depressive disorders.

Article Title: Age-related associations between routine hematological and metabolic indicators and cognitive performance in depressive disorders: an exploratory cross-sectional study

Article References: Yuan, Q., Zhang, Q., Kuang, L., & Zhang, H. (2026). Age-related associations between routine hematological and metabolic indicators and cognitive performance in depressive disorders: an exploratory cross-sectional study. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08859-4

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08859-4

Keywords: Depressive Disorders, Cognitive Performance, Neutrophil Count, Total Cholesterol, Immune-Metabolic Hypothesis, Psychiatric Research, Cross-Sectional Study, Biomarker Research, Systemic Inflammation, Mental Health, Clinical Hematology, Neuroinflammation, Cognitive Assessment, Depression-Related Impairment, Metabolic Indicators

News Source: Glenn Wilkins. (November 16, 2026). Neutrophil Counts Linked to Cognitive Performance in Depressive Disorders. Scienmag.

Tags: biomarker researchclinical hematologycognitive assessmentcognitive performanceCross-sectional StudyDepression-Related Impairmentdepressive disordersImmune-Metabolic HypothesisMental HealthMetabolic IndicatorsNeuroinflammationneutrophil countpsychiatric researchSystemic inflammationtotal cholesterol
Share12Tweet7Share2ShareShareShare1

Related Posts

Aging Lymphocytes Accumulate Senescence Marker Linked to Physical and Cognitive Decline

Aging Lymphocytes Accumulate Senescence Marker Linked to Physical and Cognitive Decline

November 16, 2026
Gendered Experiences Shape Multimorbidity Management and Care-Seeking in Malawi

Gendered Experiences Shape Multimorbidity Management and Care-Seeking in Malawi

November 16, 2026

Community Engagement Bolsters Climate Resilience in Flood-Prone Ugandan Health Systems

November 16, 2026

Researchers Develop Discrete Choice Tool for Tanzanian Healthcare Capitation Preferences

November 16, 2026

POPULAR NEWS

  • New Hangingfly Species Discovered in Mozambique Features Rare Hind Leg Structure

    New Hangingfly Species Discovered in Mozambique Features Rare Hind Leg Structure

    29 shares
    Share 12 Tweet 7
  • Psychiatric Diagnosis Faces New Risks in the Age of AI

    29 shares
    Share 12 Tweet 7
  • Fig Leaf Silver Nanoparticles Eliminate Cattle Ticks in Laboratory Bioassays

    29 shares
    Share 12 Tweet 7
  • South Korean Whipworms Lack Classic Resistance Mutations in Full-Length Genetic Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Aging Lymphocytes Accumulate Senescence Marker Linked to Physical and Cognitive Decline

Low Decisional Conflict Among Prostate Cancer Patients Seeking Germline Testing

Gendered Experiences Shape Multimorbidity Management and Care-Seeking in Malawi

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.